Niagen Bioscience Inc (NAGE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 31.47M | 33.84M | 33.99M | 31.12M | 30.48M | 29.13M | 25.58M | 22.74M | 22.15M | 21.2M | 19.5M | 20.32M |
| Revenue Growth % | 3.26% | 16.19% | 32.86% | 36.84% | 37.59% | 37.41% | 31.21% | 11.89% | -1.79% | 0.95% | 14.25% | 21.46% |
| Cost of Goods Sold | 11.5M | 12.13M | 12.06M | 10.89M | 11.15M | 10.93M | 9.34M | 9.05M | 8.7M | 8.26M | 7.53M | 7.97M |
| COGS % of Revenue | 36.53% | 35.86% | 35.48% | 35% | 36.58% | 37.52% | 36.51% | 39.78% | 39.26% | 38.96% | 38.6% | 39.2% |
| Gross Profit | 19.98M | 21.7M | 21.93M | 20.23M | 19.33M | 18.2M | 16.24M | 13.69M | 13.46M | 12.94M | 11.97M | 12.36M |
| Gross Margin % | 63.47% | 64.14% | 64.52% | 65% | 63.42% | 62.48% | 63.49% | 60.22% | 60.74% | 61.04% | 61.4% | 60.8% |
| Gross Profit Growth % | 3.34% | 19.27% | 35.02% | 47.71% | 43.66% | 40.66% | 35.68% | 10.82% | -0.46% | 7.66% | 17.26% | 23.04% |
| Operating Expenses | 18.4M | 19.6M | 17.69M | 17.04M | 14.56M | 11.09M | 14.64M | 13.95M | 14.19M | 13.11M | 13.12M | 14.67M |
| OpEx % of Revenue | 58.46% | 57.92% | 52.06% | 54.76% | 47.76% | 38.06% | 57.22% | 61.34% | 64.04% | 61.83% | 67.28% | 72.19% |
| Selling, General & Admin | 16.92M | 17.89M | 15.9M | 15.47M | 13.3M | 9.77M | 13.35M | 12.63M | 12.09M | 11.95M | 11.88M | 13.31M |
| SG&A % of Revenue | 53.76% | 52.87% | 46.78% | 49.73% | 43.64% | 33.55% | 52.18% | 55.56% | 54.58% | 56.36% | 60.91% | 65.48% |
| Research & Development | 1.48M | 1.71M | 1.79M | 1.57M | 1.26M | 1.31M | 1.29M | 1.32M | 2.1M | 1.16M | 1.24M | 1.36M |
| R&D % of Revenue | 4.71% | 5.05% | 5.28% | 5.04% | 4.13% | 4.52% | 5.04% | 5.79% | 9.46% | 5.47% | 6.37% | 6.72% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 1.58M | 2.1M | 4.24M | 3.19M | 4.77M | 7.11M | 1.6M | -256K | -731K | -168K | -1.15M | -2.32M |
| Operating Margin % | 5.01% | 6.21% | 12.46% | 10.24% | 15.66% | 24.42% | 6.26% | -1.13% | -3.3% | -0.79% | -5.88% | -11.4% |
| Operating Income Growth % | -66.97% | -70.43% | 164.42% | 1344.14% | 752.8% | 4332.74% | 239.67% | 88.95% | 62.86% | 88.37% | 62.58% | 63.74% |
| EBITDA | 1.87M | 2.97M | 4.43M | 3.54M | 5.14M | 7.47M | 1.97M | 114K | -341K | 205K | -699K | -1.87M |
| EBITDA Margin % | 5.93% | 8.77% | 13.04% | 11.38% | 16.86% | 25.64% | 7.69% | 0.5% | -1.54% | 0.97% | -3.59% | -9.21% |
| EBITDA Growth % | -63.68% | -60.28% | 125.15% | 3005.26% | 1607.33% | 3543.41% | 381.55% | 106.09% | 77.68% | 120.73% | 73.28% | 68.57% |
| D&A (Non-Cash Add-back) | 291K | 864K | 195K | 355K | 368K | 358K | 366K | 370K | 390K | 373K | 448K | 444K |
| EBIT | 1.58M | 2.1M | 4.8M | 3.19M | 4.77M | 7.11M | 1.6M | -256K | -731K | -168K | -1.15M | -2.32M |
| Net Interest Income | 375K | 552K | 564K | 552K | 459K | 373K | 276K | 241K | 239K | 282K | 188K | 125K |
| Interest Income | 375K | 552K | 564K | 552K | 459K | 373K | 276K | 241K | 239K | 282K | 188K | 125K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 5.16M | 2.32M | 564K | 552K | 459K | 373K | 276K | 241K | 239K | 282K | 188K | 125K |
| Pretax Income | 6.74M | 4.42M | 4.8M | 3.74M | 5.23M | 7.48M | 1.88M | -15K | -492K | 114K | -959K | -2.19M |
| Pretax Margin % | 21.4% | 13.07% | 14.12% | 12.01% | 17.16% | 25.7% | 7.34% | -0.07% | -2.22% | 0.54% | -4.92% | -10.78% |
| Income Tax | 417K | 292K | 222K | 128K | 168K | 305K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 6.19% | 6.6% | 4.63% | 3.43% | 3.21% | 4.08% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 6.32M | 4.13M | 4.58M | 3.61M | 5.06M | 7.18M | 1.88M | -15K | -492K | 114K | -959K | -2.19M |
| Net Margin % | 20.07% | 12.21% | 13.47% | 11.6% | 16.61% | 24.65% | 7.34% | -0.07% | -2.22% | 0.54% | -4.92% | -10.78% |
| Net Income Growth % | 24.79% | -42.44% | 143.77% | 24160% | 1129.07% | 6197.37% | 295.83% | 99.32% | 74.13% | 108.04% | 2.64% | 65.75% |
| Net Income (Continuing) | 6.32M | 4.13M | 4.58M | 3.61M | 5.06M | 7.18M | 1.88M | -15K | -492K | 114K | -959K | -2.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.07 | 0.05 | 0.05 | 0.04 | 0.06 | 0.09 | 0.02 | -0.00 | -0.01 | 0.00 | -0.01 | -0.03 |
| EPS Growth % | 22.86% | -44.37% | 119.09% | - | - | - | 288.28% | 99.32% | 74.41% | 107.81% | 11.11% | 68.8% |
| EPS (Basic) | 0.08 | 0.05 | 0.06 | 0.05 | 0.07 | 0.09 | 0.02 | -0.00 | -0.01 | 0.00 | -0.01 | -0.03 |
| Diluted Shares Outstanding | 84.57M | 84.44M | 86.62M | 86.24M | 83.23M | 81.68M | 77.77M | 75.56M | 75.23M | 75.11M | 75.05M | 74.97M |
| Basic Shares Outstanding | 79.92M | 78.97M | 91.56M | 79.25M | 77.81M | 76.94M | 93.9M | 75.56M | 75.23M | 72.89M | 75.05M | 73.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |